Industry News
Pharmaceutical Industry News
Pfizer gets an A on equality scorecard on Equal Pay Day
Pfizer gets an A on equality scorecard on Equal Pay Day sharon.coey Fri, 03/18/2022 - 12:06
After Pfizer’s pitch for 2nd round of COVID boosters, Moderna files a more ambitious FDA submission
After Pfizer's pitch for 2nd round of COVID boosters, Moderna files a more ambitious FDA submission kdunleavy Fri, 03/18/2022 - 11:16
As HAE offerings from Takeda and BioCryst gain steam, a doc survey offers lessons for the long term: analyst
As HAE offerings from Takeda and BioCryst gain steam, a doc survey offers lessons for the long term: analyst aliu Fri, 03/18/2022 - 10:35
Pfizer’s deal with Medicines Patent Pool includes 35 companies from 12 countries to produce generic Paxlovid
Pfizer's deal with Medicines Patent Pool includes 35 companies from 12 countries to produce generic Paxlovid kdunleavy Fri, 03/18/2022 - 09:33
Fierce Pharma Asia—Eisai’s reduced Aduhelm role; Chinese biotechs’ US delisting risks; Zai Lab’s new COO from Lilly
Fierce Pharma Asia—Eisai's reduced Aduhelm role; Chinese biotechs' US delisting risks; Zai Lab's new COO from Lilly aliu Fri, 03/18/2022 - 06:28
Pharma’s ‘superhero’ image fades as inflation, Ukraine drown out the industry
Pharma's 'superhero' image fades as inflation, Ukraine drown out the industry badams Fri, 03/18/2022 - 04:44
Amid sales slump, Teva CEO Schultz’s pay falls 7% to $14.7M
Amid sales slump, Teva CEO Schultz's pay falls 7% to $14.7M kdunleavy Thu, 03/17/2022 - 19:38
Merck details Keytruda’s postsurgery lung cancer win, teeing up fight against Roche’s Tecentriq
Merck details Keytruda's postsurgery lung cancer win, teeing up fight against Roche's Tecentriq aliu Thu, 03/17/2022 - 11:52
GlaxoSmithKline wraps up Shingrix recall after inspection flagged cracked vials
GlaxoSmithKline wraps up Shingrix recall after inspection flagged cracked vials jkeenan Thu, 03/17/2022 - 11:50
Alnylam sues Pfizer and Moderna claiming infringement on its delivery technology for COVID shots
Alnylam sues Pfizer and Moderna claiming infringement on its delivery technology for COVID shots kdunleavy Thu, 03/17/2022 - 11:32
Ahead of Humira’s patent cliff, AbbVie’s Rinvoq notches third new use in 4 months
Ahead of Humira's patent cliff, AbbVie's Rinvoq notches third new use in 4 months kdunleavy Thu, 03/17/2022 - 09:44
Ahead of Humira’s patent cliff, AbbVie’s Rinvoq notches 3rd new use in 4 months
Ahead of Humira's patent cliff, AbbVie's Rinvoq notches 3rd new use in 4 months kdunleavy Thu, 03/17/2022 - 09:44
Citing manufacturing ‘deviations,’ Macleods recalls drugs to treat high blood pressure, schizophrenia
Citing manufacturing 'deviations,' Macleods recalls drugs to treat high blood pressure, schizophrenia jkeenan Thu, 03/17/2022 - 09:33
Eli Lilly takes more heat for campaign contributions to election objectors
Eli Lilly takes more heat for campaign contributions to election objectors nmissakian Thu, 03/17/2022 - 09:21
Biogen’s Tecfidera patent contingency plan falls flat amid sputtering Aduhelm launch
Biogen's Tecfidera patent contingency plan falls flat amid sputtering Aduhelm launch fkansteiner Thu, 03/17/2022 - 09:13
After Alexion buyout, AstraZeneca pays Roche $775M to settle Ultomiris patent brawl
After Alexion buyout, AstraZeneca pays Roche $775M to settle Ultomiris patent brawl aliu Thu, 03/17/2022 - 08:53
Catalent completes $30M expansion at French site, adding capacity and 80 jobs
Catalent completes $30M expansion at French site, adding capacity and 80 jobs jkeenan Thu, 03/17/2022 - 08:25
Bristol Myers’ Opdivo combo Opdualag scores FDA approval in melanoma, opens 3rd immune checkpoint drug class
Bristol Myers’ Opdivo combo Opdualag scores FDA approval in melanoma, opens 3rd immune checkpoint drug class aliu Thu, 03/17/2022 - 06:26
BioNTech, CureVac part of $3.14B deal to bolster German vaccine capacity through 2029: report
BioNTech, CureVac part of $3.14B deal to bolster German vaccine capacity through 2029: report fkansteiner Wed, 03/16/2022 - 13:19
AbbVie, Eli Lilly, Novartis and more cut back in Russia amid corporate exodus over Ukraine war
AbbVie, Eli Lilly, Novartis and more cut back in Russia amid corporate exodus over Ukraine war aliu Wed, 03/16/2022 - 11:18